doi: 10.3389/fcdhc.2026.1772391 Received 20 December 2025 Revised 15 March 2026 Accepted 16 March 2026 Published 10 April 2026 Volume 7 - 2026 Edited by Arrigo Francesco Giuseppe Cicero, University of Bologna, Italy Reviewed by Alessando Mattina, IRRCS ISMETT/UPMC Italy, Italy Updates Copyright 2026 Jdrasek, Lisowska and Czupryniak
Okava, a San Francisco-based bio-pharma company which specialises in pet health, is planning to run trials for a drug designed to mimic the effects of Ozempic, with the goal to produce an implant-version for dogs, which lasts six-months at a time
Diabetes Mellitus and the Risk of Dementia: The Rotterdam Study
Your body maintains relatively stable medication levels from that point forward
Microsatellite instability in colorectal cancer 11(10):659-61, 2013
A 2003 study of 15 people with atypical depression who took 600 mcg of chromium picolinate showed no significant improvement in depression symptoms or mixed results using two depression measurement tools